B12 Solipsism

Spreading confusion over the internet since 1994

Drug Chief at the FDA Is Accused

without comments

Allegations of corruption and conflict of interest at the FDA? Really? How novel

Neon - NH Ballin Drugs Prescriptions

The inspector general of the Department of Health and Human Services is investigating a conflict-of-interest allegation involving the official in charge of drug approvals at the Food and Drug Administration, the FDA said.

The investigation of Janet Woodcock, the director of the FDA’s Center for Drug Evaluation and Research, stems from an ethics complaint filed by Amphastar Pharmaceuticals Inc., a California company that says it has been delayed in its six-year effort to win approval for a generic version of Lovenox, a multi-billion-dollar blood thinner.

In its complaint, Amphastar alleges that its competitor had special access to Dr. Woodcock at critical times in the prolonged approval process, which is ongoing. Amphastar points out that Dr. Woodcock co-authored a scientific paper with scientists at Momenta Pharmaceuticals Inc. while both companies were battling to win FDA approval of their generic blood thinners.

[Click to continue reading Drug Chief at the FDA Is Accused Of Conflict – WSJ.com]

Big Pharma owns the regulating process, makes sense they own the regulators themselves as well.

Written by Seth Anderson

August 12th, 2009 at 9:47 am

Leave a Reply